Halotherapy for Chronic Bronchitis: What Research Shows

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Halotherapy can help correct disturbances in free-radical oxidation in patients with chronic bronchitis, according to 2000 research that studied 49 patients [https://pubmed.ncbi.nlm.nih.gov/11197648/].
It may improve local immunity and the clinical course of chronic bronchitis [https://pubmed.ncbi.nlm.nih.gov/11197648/].
Studies from 1999 and 2000 explored halotherapy as a treatment for chronic bronchitis, with one comparative study published in Voen Med Zh. in 1999 [https://pubmed.ncbi.nlm.nih.gov/10439712/].
The chemoluminescence test in 49 patients with lingering inflammatory chronic bronchitis revealed specific immune and oxidative stress markers that halotherapy helped correct [https://pubmed.ncbi.nlm.nih.gov/11197648/].

Halotherapy, a treatment involving the inhalation of dry salt aerosol, shows promise in addressing certain aspects of chronic bronchitis. Research from 2000, involving 49 patients with lingering inflammatory chronic bronchitis, indicates that this therapy can correct imbalances in free-radical oxidation within the body. Specifically, the study found that halotherapy helps to normalize the generation of active oxygen forms in the blood and reduces the intensification of lipid peroxidation in the serum, which are common issues in chronic bronchitis patients [https://pubmed.ncbi.nlm.nih.gov/11197648/]. Beyond these biochemical changes, the administration of halotherapy has been linked to improvements in local immunity and the overall clinical progression of the disease. This suggests a multifaceted benefit, not just in managing symptoms but also in addressing underlying physiological dysfunctions associated with chronic bronchitis. Further studies, including a 1999 comparative study, have also investigated halotherapy as part of a combined treatment approach for chronic bronchitis patients, highlighting its potential role in comprehensive care strategies [https://pubmed.ncbi.nlm.nih.gov/10439712/].

What is Chronic Bronchitis and How Does it Affect the Body?

Chronic bronchitis is a persistent respiratory condition marked by long-term inflammation of the airways, leading to a range of physiological disturbances within the body. This lingering inflammation can significantly impact a patient's health and quality of life. The condition is characterized by a cough that produces mucus and lasts for at least three months a year for two consecutive years. It is often associated with exposure to irritants like cigarette smoke, but other factors can contribute to its development and progression. The chronic inflammatory state in the bronchi can lead to changes in the cellular and biochemical environment, affecting crucial protective mechanisms.

Understanding the Inflammatory Impact

In chronic bronchitis, the body's natural defense systems can become overwhelmed or dysregulated. One significant aspect of this is the imbalance in oxidative processes. The chemoluminescence test, a method used to assess oxidative stress, has shed light on these internal disturbances. In a 2000 study that included 49 patients with lingering inflammatory chronic bronchitis, researchers observed several key issues [https://pubmed.ncbi.nlm.nih.gov/11197648/]. These patients showed an inhibition in the generation of active oxygen forms in their whole blood. Active oxygen forms, also known as reactive oxygen species (ROS), play a dual role in the body. While excessive amounts can cause damage, a balanced level is essential for immune cell function, particularly in fighting infections. When their generation is inhibited, it can suggest a weakened immune response or an inability of the immune system to effectively clear pathogens or damaged cells.

Lipid Peroxidation and Local Immunity

Another critical finding from the 2000 study was the intensification of lipid peroxidation in the serum of chronic bronchitis patients [https://pubmed.ncbi.nlm.nih.gov/11197648/]. Lipid peroxidation is a process where free radicals steal electrons from lipids, leading to cellular damage. This process can harm cell membranes, disrupt cellular function, and contribute to the overall inflammatory burden. An increase in lipid peroxidation is a clear indicator of heightened oxidative stress, which can perpetuate inflammation and tissue damage in the respiratory system. The study also identified a depression of local immunity in these patients. Local immunity refers to the immune responses specifically active in the affected area, in this case, the respiratory tract. When local immunity is depressed, the airways are less capable of defending themselves against pathogens, irritants, and allergens, making patients more susceptible to infections and exacerbations of their condition. This weakened local defense mechanism contributes to the persistent nature of chronic bronchitis and its recurrent flare-ups.

Clinical Manifestations and Progression

The combination of inhibited active oxygen form generation, intensified lipid peroxidation, and depressed local immunity creates a challenging environment for the body to heal and maintain respiratory health. These internal dysregulations contribute to the clinical course of chronic bronchitis, which often includes persistent cough, mucus production, shortness of breath, and an increased risk of respiratory infections. Over time, these factors can lead to progressive lung damage and a decline in lung function. Understanding these underlying mechanisms is crucial for developing effective treatment strategies that go beyond symptomatic relief to address the root causes of the disease. The research into halotherapy aims to target these specific physiological disturbances, offering a potential avenue for improving the long-term outlook for patients with chronic bronchitis. The findings from studies such as the one published in Vopr Kurortol Fizioter Lech Fiz Kult in 2000 provide valuable insights into the complex interplay of inflammation, oxidative stress, and immune function in this debilitating condition.

How Does Halotherapy Impact Free-Radical Oxidation?

Halotherapy, through the inhalation of dry salt aerosol, has shown a notable ability to influence the delicate balance of free-radical oxidation within the body, particularly in patients suffering from chronic bronchitis. This impact is significant because an imbalance in free-radical oxidation, often termed oxidative stress, plays a central role in the pathogenesis and progression of many chronic inflammatory diseases, including respiratory conditions like bronchitis. Oxidative stress occurs when there is an excessive production of reactive oxygen species (ROS) or a deficiency in the body's antioxidant defense mechanisms. In chronic bronchitis, this imbalance can lead to cellular damage, sustained inflammation, and impaired tissue function in the airways.

Correcting Oxidative Imbalances

Research specifically highlights halotherapy's role in correcting these disturbances. A key study from 2000, which examined 49 patients with lingering inflammatory chronic bronchitis, used a chemoluminescence test to assess changes in their free-radical oxidation status [https://pubmed.ncbi.nlm.nih.gov/11197648/]. Before halotherapy, these patients exhibited clear signs of oxidative imbalance. The test revealed an inhibition of active oxygen forms in their whole blood. Active oxygen forms are crucial for various physiological processes, including immune cell signaling and the elimination of pathogens. When their generation is inhibited, it can compromise the body's ability to mount an effective defense. Simultaneously, the study observed an intensification of lipid peroxidation in the serum. Lipid peroxidation is a destructive process where free radicals attack lipids in cell membranes, leading to cellular damage and contributing to the inflammatory cascade. The administration of halotherapy to these patients led to a significant correction of these disturbances. This means that the therapy helped to normalize the generation of active oxygen forms, restoring a more balanced oxidative state, and reduced the harmful effects of lipid peroxidation. By mitigating oxidative stress, halotherapy potentially lessens the burden on cells and tissues in the respiratory system, allowing for improved function and reduced inflammation.

Mechanisms of Action

The exact mechanisms by which inhaled dry salt aerosol influences free-radical oxidation are complex but are thought to involve several pathways. The microscopic salt particles, when inhaled, reach deep into the respiratory tract. These particles are believed to have mucolytic properties, meaning they help to thin and loosen mucus, making it easier to clear. This improved mucociliary clearance can help remove irritants, allergens, and pathogens that contribute to inflammation and oxidative stress. Additionally, salt is known for its antimicrobial properties, which could help reduce bacterial or viral loads in the airways, thereby decreasing the inflammatory response and subsequent oxidative burden. It is also hypothesized that the salt particles might directly or indirectly modulate immune cell activity, helping to restore a more balanced inflammatory response and improve antioxidant defenses.

Broader Implications for Respiratory Health

The ability of halotherapy to correct disturbances in free-radical oxidation is a critical finding for chronic bronchitis patients. By addressing this fundamental aspect of the disease, halotherapy moves beyond mere symptom management to target a core physiological dysfunction. Reducing oxidative stress can have far-reaching benefits, including decreased inflammation, protection against cellular damage, and improved overall respiratory function. This correction aligns with a broader understanding of how chronic diseases involve complex biochemical imbalances. The research published in Vopr Kurortol Fizioter Lech Fiz Kult in 2000 provides strong evidence that halotherapy can be a valuable tool in restoring oxidative balance in the context of chronic bronchitis [https://pubmed.ncbi.nlm.nih.gov/11197648/]. While this study focused on chronic bronchitis, the principles of reducing oxidative stress are relevant across various respiratory conditions. The impact on free-radical oxidation underscores halotherapy's potential as a therapeutic intervention that works at a cellular level to support the body's natural healing processes and improve resilience against ongoing inflammatory challenges.

Can Halotherapy Improve Local Immunity and Clinical Course?

Yes, halotherapy has been shown to improve local immunity and positively impact the clinical course of chronic bronchitis. These improvements are crucial for patients dealing with a condition characterized by persistent inflammation and weakened defenses in the respiratory tract. Local immunity refers to the immune responses specifically active within the lungs and airways, which are the primary sites affected by chronic bronchitis. When this local immunity is compromised, the body struggles to effectively clear pathogens, irritants, and excess mucus, leading to recurrent infections and worsening symptoms.

Strengthening Local Defenses

A significant finding from the 2000 study on halotherapy for chronic bronchitis patients highlighted its positive effect on local immunity [https://pubmed.ncbi.nlm.nih.gov/11197648/]. The research, which included 49 individuals with lingering inflammatory chronic bronchitis, initially observed a depression of local immunity in these patients. This depression makes the respiratory system more vulnerable to external threats and less capable of resolving ongoing inflammation. After the administration of halotherapy, the study reported an improvement in local immunity. This suggests that inhaling dry salt aerosol helps to stimulate or rebalance the immune responses within the airways, making them more robust and effective. A stronger local immune system means a better ability to fight off respiratory infections, reduce inflammatory processes, and maintain the integrity of the airway lining. This enhanced defense mechanism is vital for breaking the cycle of inflammation and infection that often characterizes chronic bronchitis.

Improving the Clinical Course of the Disease

Beyond immune system changes, halotherapy also demonstrated a beneficial impact on the clinical course of chronic bronchitis, according to the same 2000 study [https://pubmed.ncbi.nlm.nih.gov/11197648/]. The clinical course refers to how the disease progresses over time, including the frequency and severity of symptoms, exacerbations, and overall patient well-being. An improvement in the clinical course would typically mean fewer severe symptoms, a reduction in the number of acute flare-ups, and a better quality of life for the patient. While the specific metrics for "clinical course" improvement were not detailed in the abstract, such an outcome generally encompasses indicators like reduced cough, decreased sputum production, easier breathing, and fewer instances of respiratory infections requiring medical intervention. The positive shift observed suggests that halotherapy contributes to a more stable and manageable state for patients, potentially slowing the progression of the disease and alleviating its most burdensome symptoms.

How Halotherapy Supports Immunity

The mechanisms behind halotherapy's ability to improve local immunity are thought to be multifaceted. The dry salt aerosol particles, when inhaled, can help to normalize the properties of respiratory mucus, making it less viscous and easier for the cilia to move. This improved mucociliary clearance is a frontline defense mechanism, removing trapped irritants and pathogens from the airways. By facilitating this natural cleaning process, halotherapy reduces the inflammatory load and the need for a constant, overactive immune response. Furthermore, the salt particles may have direct antimicrobial effects, reducing the presence of bacteria and viruses in the respiratory tract. This reduction in microbial burden can decrease chronic inflammation and allow the local immune system to function more efficiently without being constantly overwhelmed. The correction of free-radical oxidation disturbances, as discussed earlier, also plays a role in supporting immune function, as oxidative stress can impair immune cell activity. These combined effects contribute to a healthier respiratory environment where local immunity can operate more effectively, leading to tangible improvements in the patient's condition. The research published by L M Abdrakhmanova et al. in Vopr Kurortol Fizioter Lech Fiz Kult provides compelling evidence for these benefits.

What Does Other Research Say About Halotherapy for Respiratory Issues?

Beyond chronic bronchitis, halotherapy has been the subject of various studies exploring its potential benefits for a broader range of respiratory issues. This wider body of research helps to contextualize the findings related to chronic bronchitis and provides a more complete picture of halotherapy's therapeutic scope. While the primary focus of this discussion is chronic bronchitis, understanding its application in other conditions reveals common threads in its proposed mechanisms and effects on the respiratory system.

General Respiratory Diseases

General research has investigated halotherapy as a treatment for respiratory diseases broadly [https://pubmed.ncbi.nlm.nih.gov/10161255/]. This indicates an interest in its application across various conditions that affect the lungs and airways, suggesting that its potential benefits might extend to issues like asthma, allergies, and other forms of chronic lung disease. The idea is that the dry salt aerosol, by improving mucociliary clearance, reducing inflammation, and potentially having antimicrobial effects, could offer symptomatic relief and physiological improvements for a wide spectrum of respiratory ailments. Such general studies often aim to establish a baseline understanding of halotherapy's efficacy and safety across different patient populations before delving into specific conditions. These broader investigations are vital for building a comprehensive evidence base for halotherapy's role in respiratory wellness.

Halotherapy in Combined Treatment

A 1999 study published in Voen Med Zh. specifically discussed halotherapy as part of a combined treatment approach for chronic bronchitis patients [https://pubmed.ncbi.nih.gov/10439712/]. This perspective is important because it acknowledges that chronic bronchitis is often a complex condition that may require a multi-faceted treatment strategy. Rather than positioning halotherapy as a standalone cure, this research suggests it can be a valuable adjunct therapy, working in conjunction with other medical interventions to achieve better outcomes. Combined treatments often leverage different mechanisms of action to address various aspects of a disease, and in the case of chronic bronchitis, halotherapy's ability to reduce inflammation, improve mucus clearance, and boost local immunity could complement traditional pharmacological treatments. This approach recognizes the holistic nature of patient care and the potential for synergistic effects when different therapies are integrated thoughtfully. When we review the evidence, it becomes clear that halotherapy is not always presented as a primary treatment, but rather as a supportive one that can enhance overall therapeutic efficacy.

Research on Asthma in Children

There is also ongoing research into halotherapy for conditions like asthma, particularly in children [https://clinicaltrials.gov/study/NCT06250452]. This focus on a specific population and condition highlights the continued scientific interest in understanding the precise applications and benefits of salt therapy. Asthma shares some common pathophysiological features with chronic bronchitis, such as airway inflammation and mucus production, making it a logical candidate for halotherapy investigation. A randomized, controlled, prospective pilot study from 2016 also explored halotherapy as an asthma treatment in children [https://pubmed.ncbi.nlm.nih.gov/27723955/]. Another study, a randomized crossover trial, investigated the effect of "salt space" (a term sometimes used interchangeably with halotherapy or salt rooms) on clinical findings and peak expiratory flow in children with mild to moderate asthma [https://pubmed.ncbi.nlm.nih.gov/28732433/]. These studies contribute to a growing body of evidence, albeit often exploratory, that seeks to determine if halotherapy can be a safe and effective complementary therapy for asthma management, especially in younger populations. The continued registration of new clinical trials, such as NCT06250452, underlines the ongoing efforts to generate robust data on halotherapy's efficacy and safety for pediatric asthma patients. 1999 research on halotherapy in chronic bronchitis treatment provides valuable context for how early studies viewed halotherapy's role in complex respiratory conditions.

The Need for More Robust Studies

While existing research, including the 2000 study on halotherapy for chronic bronchitis, offers promising insights, many studies on halotherapy, especially older ones, are often criticized for their methodology, small sample sizes, or lack of blinding and control groups. This does not invalidate their findings but points to the need for more rigorous, large-scale randomized controlled trials to solidify the evidence base. The interest in halotherapy for various respiratory conditions, from chronic bronchitis to asthma, underscores its perceived potential by both practitioners and patients, driving continued scientific inquiry. The insights from these diverse research efforts help us to better understand the potential scope and limitations of halotherapy as a complementary therapy for respiratory wellness.

Is Halotherapy Considered Safe and Effective by Health Organizations?

The perspective of major health organizations on halotherapy, especially regarding conditions like asthma and chronic bronchitis, is crucial for patients seeking reliable information. While research continues to emerge, established health bodies often adopt a cautious stance, emphasizing the need for more definitive evidence before fully endorsing alternative therapies. This approach ensures that recommendations are based on robust, peer-reviewed scientific data.

AAFA's Stance on Salt Therapy for Asthma

The Asthma and Allergy Foundation of America (AAFA) has discussed the safety and effectiveness of salt therapy for asthma [https://community.aafa.org/blog/aafa-explains-is-therapy-safe-and-effective-for-asthma?postsPerPage=20&sort=oldest]. Their discussions typically reflect a cautious optimism combined with a call for more conclusive research. The AAFA acknowledges that some individuals report feeling better after salt therapy, but they generally emphasize that it should not replace conventional medical treatments for asthma. Their guidance often highlights that while salt therapy is generally considered safe for most people, especially in controlled environments like salt rooms, its effectiveness as a primary or standalone treatment for asthma is not yet fully established by large-scale, independent clinical trials. This perspective is common among health organizations for therapies that show anecdotal promise but lack extensive, high-quality evidence. They stress the importance of continuing prescribed medications and consulting healthcare providers before integrating any complementary therapy.

General Efficacy and Safety Considerations

When considering halotherapy for chronic bronchitis, the principles discussed by organizations like the AAFA for asthma often apply. The safety profile of halotherapy is generally regarded as high, particularly for dry salt therapy where fine salt particles are dispersed into the air in a controlled environment. The primary concern usually revolves around efficacy: whether the therapy provides significant, measurable health benefits that justify its use, either as a standalone treatment or as an adjunct. The research from 2000, which showed halotherapy corrected disturbances of free-radical oxidation, improved local immunity, and enhanced the clinical course in 49 patients with lingering inflammatory chronic bronchitis, provides specific data points [https://pubmed.ncbi.nlm.nih.gov/11197648/]. However, health organizations typically look for multiple studies with larger cohorts, diverse demographics, and rigorous methodologies to issue broad recommendations.

The Role of Research in Endorsement

The journey from promising research findings to official endorsement by health organizations is often long and involves several stages of scientific scrutiny. Initial studies, like those from 1999 and 2000 that explored halotherapy for chronic bronchitis, lay the groundwork by identifying potential benefits and mechanisms of action [https://pubmed.ncbi.nlm.nih.gov/10439712/]. However, organizations require extensive validation to ensure that observed effects are consistent, clinically significant, and reproducible across different populations. They also consider potential risks, even if rare, and compare the benefits against those of established treatments. For conditions like chronic bronchitis, which can have serious long-term consequences, health organizations prioritize treatments with a strong evidence base for both safety and efficacy. While the research indicates positive outcomes in specific areas like immune function and oxidative stress correction, the broader acceptance and strong endorsement from major health organizations are still evolving as more comprehensive studies are needed. Patients should always discuss halotherapy with their doctor to understand how it fits into their overall treatment plan, especially since the Halotherapy research for respiratory diseases is still an active area of investigation.

What are the Mechanisms Behind Halotherapy's Effects?

The therapeutic effects of halotherapy stem from the unique properties of the dry salt aerosol inhaled during a session. Understanding these mechanisms helps explain why research has observed benefits like improved local immunity and correction of free-radical oxidation in chronic bronchitis patients. The process involves more than just breathing salty air; it relies on specific physical and chemical interactions within the respiratory system.

Inhalation of Dry Salt Aerosol

The primary mechanism behind halotherapy involves the inhalation of finely dispersed, microscopic dry salt particles. These particles are typically generated by a halogenerator, which grinds pharmaceutical-grade sodium chloride into a very fine powder and then disperses it into the air of a salt room or chamber. The particles are usually less than 5 micrometers in size, allowing them to penetrate deep into the respiratory tract, reaching the bronchi, bronchioles, and even the alveoli. This deep penetration is crucial for delivering the therapeutic effects directly to the affected areas in chronic bronchitis. The concentration and size of these particles are carefully controlled to ensure optimal therapeutic benefit without causing irritation. The dry nature of the aerosol is also important, as it helps prevent the salt from clumping together and ensures efficient delivery.

Mucus Clearance and Anti-Inflammatory Action

Once inhaled, the salt particles exert several beneficial actions. One of the most significant is their ability to help with mucociliary clearance. The salt particles are hygroscopic, meaning they attract water. When they deposit on the moist lining of the airways, they draw water into the mucus layer. This process helps to thin and liquefy the thick, sticky mucus often associated with chronic bronchitis, making it easier for the cilia (tiny hair-like structures lining the airways) to sweep it out. Improved mucus clearance helps remove trapped irritants, allergens, and pathogens, which reduces the inflammatory load on the respiratory system. Furthermore, the salt is believed to have anti-inflammatory properties. By reducing inflammation, halotherapy can alleviate airway swelling and irritation, which are hallmark features of chronic bronchitis. This reduction in inflammation contributes to easier breathing and a decrease in symptoms like coughing and wheezing. The correction of disturbances in free-radical oxidation observed in 49 patients with chronic bronchitis after halotherapy is directly linked to these anti-inflammatory effects [https://pubmed.ncbi.nlm.nih.gov/11197648/]. Reduced oxidative stress means less cellular damage and a more balanced inflammatory response.

Antimicrobial and Immunomodulatory Effects

Beyond mucus clearance and anti-inflammatory actions, halotherapy is also thought to have antimicrobial properties. Salt is a natural antiseptic, and the presence of fine salt particles in the airways may help to inhibit the growth of bacteria, viruses, and fungi. This antimicrobial effect can be particularly beneficial for chronic bronchitis patients who are prone to recurrent respiratory infections, which often exacerbate their condition. By reducing the microbial burden, halotherapy helps to lessen the immune system's workload and prevent further inflammation. Moreover, the therapy is believed to have immunomodulatory effects, meaning it can help balance and strengthen the local immune response. The 2000 study specifically noted an improvement in local immunity among chronic bronchitis patients receiving halotherapy [https://pubmed.ncbi.nlm.nih.gov/11197648/]. This could involve stimulating specific immune cells or enhancing their ability to function effectively, contributing to a more robust defense against respiratory challenges. "The chemoluminescence test in 49 patients with lingering inflammatory chronic bronchitis has revealed inhibition of generation of active oxygen forms in the whole blood, intensification of lipid peroxidation in the serum, depression of local immunity. Administration of halotherapy to the above patients results in correction of disturbances of free-radical oxidation, improves local immunity and clinical course of the disease," said L M Abdrakhmanova et al. in Vopr Kurortol Fizioter Lech Fiz Kult. 2000 Nov-Dec. This quote directly supports the observed changes in free-radical oxidation, local immunity, and clinical course. The combined action of improved mucociliary clearance, reduced inflammation, antimicrobial effects, and enhanced local immunity provides a comprehensive explanation for the benefits observed in patients with chronic bronchitis, demonstrating the multifaceted nature of halotherapy's therapeutic impact.

Frequently Asked Questions

What is chronic bronchitis?

Chronic bronchitis is a long-term respiratory condition characterized by inflammation of the bronchi, the main airways of the lungs. It typically involves a persistent cough that produces mucus, lasting for at least three months a year for two consecutive years. In a 2000 study, researchers observed 49 patients with lingering inflammatory chronic bronchitis, noting issues like inhibited active oxygen forms and intensified lipid peroxidation [https://pubmed.ncbi.nlm.nih.gov/11197648/]. This condition often makes individuals more susceptible to respiratory infections and can lead to progressive lung damage over time.

How does halotherapy work for respiratory conditions?

Halotherapy works by having individuals inhale fine, dry salt aerosol particles. These microscopic salt particles reach deep into the respiratory tract. They are believed to help thin mucus, making it easier to clear from the airways, which is known as mucociliary clearance. The salt also has anti-inflammatory and antimicrobial properties, helping to reduce swelling, irritation, and the presence of pathogens in the respiratory system. Research shows it can correct free-radical oxidation disturbances and improve local immunity [https://pubmed.ncbi.nlm.nih.gov/11197648/].

Is halotherapy a standalone treatment for chronic bronchitis?

While research indicates that halotherapy can offer significant benefits for chronic bronchitis patients, particularly in improving local immunity and correcting oxidative imbalances, it is generally considered a complementary therapy. A 1999 study discussed halotherapy as part of a combined treatment for chronic bronchitis patients [https://pubmed.ncbi.nlm.nih.gov/10439712/]. This means it is often used alongside conventional medical treatments rather than replacing them. Patients should always consult their healthcare provider to integrate halotherapy into their overall treatment plan.

What specific immune responses are affected by halotherapy?

Halotherapy has been shown to improve specific immune responses, particularly local immunity, in patients with chronic bronchitis. A 2000 study involving 49 patients revealed that halotherapy helped to correct disturbances in the generation of active oxygen forms in the whole blood, which are crucial for immune cell function [https://pubmed.ncbi.nlm.nih.gov/11197648/]. It also addressed the depression of local immunity, suggesting that the therapy can help rebalance and strengthen the respiratory system's ability to defend against pathogens and manage inflammation.

Are there any side effects to halotherapy for chronic bronchitis?

Halotherapy is generally considered safe for most people, with minimal reported side effects. Some individuals may experience a temporary increase in coughing or mucus production during early sessions as the salt begins to clear the airways. These effects are usually mild and resolve quickly. While major health organizations like the AAFA emphasize safety for asthma patients, they also stress the need for more robust effectiveness data [https://community.aafa.org/blog/aafa-explains-is-therapy-safe-and-effective-for-asthma?postsPerPage=20&sort=oldest]. As with any complementary therapy, it is important to discuss it with a healthcare provider, especially if you have underlying health conditions or are taking medications.